Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. 1986

P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson

Bone marrow and/or peripheral blood samples from 133 (75%) of a total of 177 consecutive previously untreated protocol patients with acute nonlymphoblastic leukemia (ANLL) were analyzed for terminal deoxynucleotidyl transferase (TdT) activity at the time of presentation. Twenty-nine (22%) were found to exhibit TdT activity (greater than or equal to 0.10 U/10(8) cells, TdT+) as measured in a biochemical microassay. There were no differences between TdT+ as compared with TdT-negative (TdT-) patients with respect to age, sex, French-American-British (FAB) classification, or the presence of Auer's rods. Remission induction rates were higher for the TdT- patients, with 68% v 48% for the TdT+ patients (P = .05). TdT- patients also experienced longer remissions (P = .003) than TdT+ patients, especially in the Auer's rod-positive subgroup (P = .002). None of five patients with TdT+ ANLL treated with vincristine and prednisone as initial therapy achieved complete remission; all required induction regimens containing daunorubicin or amsacrine in combination with cytosine arabinoside and 6-thioguanine. It is concluded that TdT activity in ANLL indicates biphenotypia or lineage infidelity and is associated with a poor prognosis on chemotherapy protocols currently used for the treatment of ANLL.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004253 DNA Nucleotidylexotransferase A non-template-directed DNA polymerase normally found in vertebrate thymus and bone marrow. It catalyzes the elongation of oligo- or polydeoxynucleotide chains and is widely used as a tool in the differential diagnosis of acute leukemias in man. EC 2.7.7.31. Terminal Addition Enzyme,Terminal Deoxyribonucleotidyltransferase,Deoxynucleotidyl Transferase,Deoxynucleotidyltransferase,Desoxynucleotidyl Transferase,Desoxynucleotidyltransferase,Tdt Antigen,Terminal Deoxynucleotidyl Transferase,Terminal Deoxyribonucleotidyl Transferase,Addition Enzyme, Terminal,Antigen, Tdt,Deoxynucleotidyl Transferase, Terminal,Deoxyribonucleotidyl Transferase, Terminal,Deoxyribonucleotidyltransferase, Terminal,Enzyme, Terminal Addition,Nucleotidylexotransferase, DNA,Transferase, Deoxynucleotidyl,Transferase, Desoxynucleotidyl,Transferase, Terminal Deoxynucleotidyl,Transferase, Terminal Deoxyribonucleotidyl
D004254 DNA Nucleotidyltransferases Enzymes that catalyze the incorporation of deoxyribonucleotides into a chain of DNA. EC 2.7.7.-. Nucleotidyltransferases, DNA
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
June 1994, Leukemia,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
October 1976, Cancer research,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
January 1979, Haematology and blood transfusion,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
May 1985, Cancer,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
January 2000, Archives of pathology & laboratory medicine,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
January 1981, American journal of hematology,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
August 1993, Leukemia,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
January 1982, Leukemia research,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
April 1975, Research communications in chemical pathology and pharmacology,
P Benedetto, and R Mertelsmann, and T H Szatrowski, and M Andreeff, and T Gee, and Z Arlin, and S Kempin, and B Clarkson
January 1982, Advances in experimental medicine and biology,
Copied contents to your clipboard!